Advertisement

Why Autolus Therapeutics Stock Skyrocketed Today

Why Autolus Therapeutics Stock Skyrocketed Today

Shares of Autolus Therapeutics (NASDAQ: AUTL) were trading 35% higher as of 3:37 p.m. EDT on Wednesday. Autolus stated that AUTO1's results will be included in an abstract presentation at the European Hematology Association (EHA) Virtual Congress scheduled for June 9 through June 17. The company said that of the 10 patients who had received AUTO1 as of Feb. 18, nine were evaluable.